WallStreetZenWallStreetZen

NASDAQ: FENC
Fennec Pharmaceuticals Inc Stock Ownership - Who owns Fennec Pharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Fennec Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Adrian HaighCHIEF OPERATING OFFICER2024-04-1622,222$2.31
$51.33kSell
Adrian HaighCHIEF OPERATING OFFICER2024-04-1622,222$10.28
$228.40kSell
Adrian HaighCHIEF OPERATING OFFICER2024-04-1522,222$10.30
$228.80kSell
Chris A. RallisDirector2024-04-151,389$10.45
$14.52kBuy
Chris A. RallisDirector2024-04-15800$10.45
$8.36kSell
Adrian HaighCHIEF OPERATING OFFICER2024-04-1522,222$2.31
$51.33kSell
Rosty RaykovCHIEF EXECUTIVE OFFICER2024-04-0544,300$10.75
$476.27kSell
Rosty RaykovCHIEF EXECUTIVE OFFICER2024-04-0414,583$10.89
$158.87kSell
Rosty RaykovCHIEF EXECUTIVE OFFICER2024-04-0429,700$10.89
$323.52kSell
Rosty RaykovCHIEF EXECUTIVE OFFICER2024-04-0326,000$10.78
$280.25kSell

1 of 4

FENC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FENC insiders and whales buy or sell their stock.

FENC Shareholders

What type of owners hold Fennec Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Southpoint Capital Advisors LP753.06%204,077,214$1.98BInsider
Robert W. Butts459.46%124,512,000$1.21BInsider
Southpoint Capital Advisors LP15.05%4,077,214$39.55MInstitution
Southpoint Master Fund LP14.75%3,997,214$38.77MInsider
Spa Essetifin14.74%3,993,694$38.74MInsider
Sonic GP LLC8.88%2,407,357$23.35MInstitution
Manchester Management Pr LLC8.06%2,184,023$21.19MInsider
Manchester Management Co LLC8.06%2,184,023$21.19MInsider
Solas Capital Management LLC5.09%1,378,513$13.37MInstitution
William G. Breen5.05%1,367,781$13.27MInsider

1 of 3

FENC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FENC4.18%95.82%Net BuyingNet Selling
VSTM25.42%74.58%Net SellingNet Selling
VTYX39.06%60.94%Net SellingNet Selling
IMMP0.17%0.00%
PYXS15.13%36.17%Net Selling
View Top Biotech Stocks

Fennec Pharmaceuticals Stock Ownership FAQ

Who owns Fennec Pharmaceuticals?

Fennec Pharmaceuticals (NASDAQ: FENC) is owned by 55.39% institutional shareholders, 1,271.11% Fennec Pharmaceuticals insiders, and 0.00% retail investors. Southpoint Capital Advisors LP is the largest individual Fennec Pharmaceuticals shareholder, owning 204.08M shares representing 753.06% of the company. Southpoint Capital Advisors LP's Fennec Pharmaceuticals shares are currently valued at $1.95B.

If you're new to stock investing, here's how to buy Fennec Pharmaceuticals stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.